News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|December 23, 2024

Advancing IgA Nephropathy Care: Emerging Therapies, Unmet Needs, and Economic Considerations

Episodes in this series

EP. 1 Advancing IgA Nephropathy Care: Emerging Therapies, Unmet Needs, and Economic Considerations

EP. 1 Advancing IgA Nephropathy Care: Emerging Therapies, Unmet Needs, and Economic Considerations

4 experts are featured in this series.

EP. 2 Introduction to IgA Nephropathy

4 experts are featured in this series.

EP. 3 Pathogenesis of IgA Nephropathy: The 4-Hit Cascade, A Proliferation-Inducing Ligand (APRIL), and cytokines

4 experts are featured in this series.

EP. 4 Diagnosing IgA Nephropathy

4 experts are featured in this series.

EP. 5 Signs and Symptoms of IgA Nephropathy

4 experts are featured in this series.

EP. 6 Challenges in Timely Identification of IgA Nephropathy

4 experts are featured in this series.

EP. 7 Clinical Impact of IgA Nephropathy and Quality of Life

4 experts are featured in this series.

EP. 8 Overview of Treatment Landscape for IgA Nephropathy: Standard of Care and KDIGO Guidelines

4 experts are featured in this series.

EP. 9 Current Treatments for IgA Nephropathy and the 4-Hit Cascade

4 experts are featured in this series.

EP. 10 Gaps in Patient Care for IgA Nephropathy

4 experts are featured in this series.

EP. 11 Emerging Anti-BAFF and Anti-APRIL Therapies

4 experts are featured in this series.

EP. 12 Emerging Therapies: Other Strategies and Important Considerations

4 experts are featured in this series.

EP. 13 The Promise of Emerging Therapies for IgA Nephropathy and Future KDIGO Guidelines

4 experts are featured in this series.

EP. 14 Sequencing and Individualizing Treatments for IgA Nephropathy

4 experts are featured in this series.

EP. 15 Measuring Success in IgA Nephropathy in Clinical Practice

4 experts are featured in this series.

EP. 16 Economic Impact of IgA Nephropathy for Patients

4 experts are featured in this series.

EP. 17 Early Diagnosis and Cost Mitigation in IgA Nephropathy

4 experts are featured in this series.

EP. 18 Cost Implications of Modulating IgA Nephropathy Disease Course

4 experts are featured in this series.

EP. 19 Patient-Reported Outcomes in the Treatment of IgA Nephropathy

4 experts are featured in this series.

EP. 20 Future Possibilities for Step Therapy in IgA Nephropathy Treatment

4 experts are featured in this series.

EP. 21 Key Managed Care Considerations for IgA Nephropathy Treatment

4 experts are featured in this series.

EP. 22 Key Economic Considerations in IgA Nephropathy: Progression to Chronic Kidney Disease

4 experts are featured in this series.

EP. 23 Closing Thoughts About IgA Nephropathy Treatment

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

4 Experts are featured in this series

Switching Therapies, Managing Adverse Effects, and Adherence Challenges

ByGus Alva, MD, DFAPA,Rishi Kakar, MD,Philip Harvey, MD,Gerald Maguire, MD

December 29th 2025

4 Experts are featured in this series

First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing

ByGus Alva, MD, DFAPA,Rishi Kakar, MD,Philip Harvey, MD,Gerald Maguire, MD

December 29th 2025

4 experts are featured in this series.

Linvoseltamab for Relapsed/Refractory Multiple Myeloma

ByRyan Haumschild, PharmD, MS, MBA,Shahrier Hossain, PharmD,Michael Singel, PharmD,Naresh Bumma, MD

December 29th 2025

4 experts are featured in this series.

CAR-T Scheduling and the Role of Combination Therapy

ByRyan Haumschild, PharmD, MS, MBA,Shahrier Hossain, PharmD,Michael Singel, PharmD,Naresh Bumma, MD

December 29th 2025

Unmet Needs and the Future of Desmoid Tumor Management

ByScott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA ,Mrinal Gounder, MD,Gina D'Amato, MD,Ryan Haumschild, PharmD, MS, MBA,Richard Riedel, MD,Alexander Lazar, M.D., Ph.D

December 23rd 2025

Trending on AJMC

Top 5 Most-Read HIV Articles of 2025

New Evidence Shows Exercise Could Ease Key Symptoms of Ovarian Cancer

ICYMI: Highlights From ASH 2025

Sleep Apnea Risk Tied to 40% Higher Odds of Poor Mental Health

The Top 5 Most-Read Multiple Myeloma Content of 2025

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.